Eliminating drug target interference with specific antibody or its F(ab′)2 fragment in the bridging immunogenicity assay
Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China
School of Pharmacy, University of Chinese Academy of Sciences, Beijing, 100049, China
Comments (0)